Many if not most tissues need a controlled number of stem cells to maintain normal function. Cancer can be seen as a process of disturbed tissue homeostasis, in which too many cells have or acquire too primitive identity. Here we measured how oncogenes and tumour suppressors affect the differentiation capacity, proportion and characteristics of progenitor cells in a model tissue. Neural progenitor cells (NPCs) were exposed to human papilloma virus E6, E7 or E6/E7 oncogenes, which degrade tumour suppressors p53 and pRb family members, respectively. E6/E7-expressing or p53À/À NPCs were able to differentiate, but simultaneously retained high capacity for self-renewal, proliferation, ability to remain multipotent in conditions promoting differentiation and showed delayed cell cycle exit. These functions were mediated through p53 and pRb family, and involved MEK-ERK signalling. Decreased amount of p53 increased selfrenewal and proliferation, whereas pRb affected only proliferation. Our results suggest that the oncogenes increase whereas p53 and pRb family tumour suppressors decrease the number and proportion of progenitor cells. These findings provide one explanation how oncogenes and tumour suppressors control tissue homeostasis and highlight their importance in stem cell self-renewal, linked both to cancer and life-long tissue turnover.
Introduction
The existence of stem cells throughout the lifespan of the individual is due to the ability to self-renew. Upon differentiation, stem cells divide asymmetrically, and produce one committed precursor cell and one stem cell to maintain the stem cell pool. Interestingly, the same mechanisms that keep the stem cells primitive are often activated in malignant transformation, in which the cells acquire uncontrolled capacity for self-renewal . These cancer and normal stem cells share several characteristics and often express the same markers and factors (Singh et al., 2003) .
One of the most important questions in cancer and stem cell biology is the mechanism of self-renewal. As several virus oncogenes (Dyson et al., 1993; Harris et al., 1998; Whyte et al., 1988; DeCaprio 1999) contribute to tumorigenesis, we addressed the question: what happens if the cells with self-renewal capacity are exposed to viral oncogenes? For this, we transduced neural progenitor cells (NPCs) with HPV 16 E6 and E7 oncogenes. HPV 16 E6/E7 is a classical oncogene complex (Fehrmann and Laimins, 2003) and an established risk factor for HPV-related cervix cancers and head and neck squamous cell carcinomas (Walboomers et al., 1999; van Houten et al., 2001) . In HPV-infected cells, E6 and E7 oncogenes degrade the tumour suppressor p53 and pRb/p107/p130, respectively (Scheffner et al., 1990; Davies et al., 1993; Boyer et al., 1996) and interfere with several other cellular activities (reviewed by Munger et al., 2004) . E6/E7 immortalize and transform at least keratinocytes, epithelial and endothelial cells (Hawley-Nelson et al., 1989; Coursen et al., 1997) .
During their differentiation to neurons, NPCs undergo changes that are considered normally irreversible. These include cell cycle exit, which involves the activation of tumour suppressors p53 (Miller et al., 2003) and pRb (Slack et al., 1993; Slack et al., 1998) . Both of them are important at various times of brain development (reviewed by Choi and Donehower, 1999) , and their deficiency frequently results in brain anomalies (Armstrong et al., 1995) or embryonic death (Macleod et al., 1996; Slack et al., 1998) . The role of pRb family members in terminal differentiation of neurons seems to be complex, as pRb has both cell cycle (cell-autonomous) and differentiation controlling functions (noncell-autonomous) (Liu et al., 2004) . Other Rb family members, p107 and p130, have also a role in differentiation (Callaghan et al., 1999; Liu et al., 2004) . The arguably most important function of p53 in neurons is to prevent cell cycle re-entry (Miller et al., 2003) . Interestingly, increasing the amount of p53 seems to accelerate the ageing of several tissues (Tyner et al., 2002) , which can be seen as a failure to keep up the normal homeostasis of tissues.
Here, we have analysed the effects of common oncogenic alterations to behaviour of progenitors or stem cells. Our results show that the oncogenes degrading p53/ Rb increase the proportion of NPCs with stem cell-related characteristics, and p53 and pRb family are involved in the process. Our results suggest that these tumour suppressors, which are known to have a role in controlling cell proliferation and tumour development, also regulate the self-renewal, maintenance and proliferation of NPCs, the balance of which is disturbed by oncogenes.
Results

HPV16 E6/E7 oncogenes increase cell proliferation and self-renewal of NPCs
To study the effects of E6 and E7 on NPC characteristics, we transduced them with retroviruses expressing these proteins separately or together. After transduction and antibiotic selection, the transgene expressions were confirmed by reverse transcriptase-PCR (Figure 1a) . Western blotting showed a clear reduction in the levels of p53 by E6 oncogene and pRb, p130 and p107 were degraded by E7 oncogene (Figure 1b ). E6 also decreased p107 level in NPCs, but we did not find the same effect in NPCs taken from p53-deficient mice ( Figure 1b) . Next, we measured the effect of the oncogenes and p53 deficiency on cell proliferation by bromodeoxyuridine (BrdU) incorporation and MTT assay (data not shown). The analyses showed markedly increased proliferation as well as shorter population-doubling time of the E7-and E6/E7-transduced or p53À/À NPCs when compared to controls (Figure 1c) .
Neurospheres are heterogeneous population of stem cells, progenitors and differentiated cells, but the pathways that maintain a certain number of cells undifferentiated are not well known. We studied whether E6, E7 and E6/E7 oncogenes affect the proportion of cells with C o n t r o l W t p 5 3 + / -p 5 3 -/ -E 6 E 6 / E 7 E 7
BrdU positive cells (%) (Figure 1d and data not shown). The secondary E6/E7 spheres were also bigger than controls, likely because of the enhanced proliferation rate. Self-renewal was also increased in E7-and slightly in E6-expressing NPCs. Also p53 deficiency increased self-renewal capacity (Figure 1d ). However, we could not find statistical significance in the selfrenewal capacity of E6-expressing or p53 þ /À NPCs when compared to controls. The clonally formed secondary spheres were all able to produce immunohistochemically positive neurons and astrocytes, which indicates that the spheres were derived from a multipotent progenitor and not from more committed cell.
E6/E7 oncogenes induce or maintain sphere-forming capacity in an environment promoting differentiation To investigate how oncogene-transduced NPCs respond to differentiation signals, we cultured cells in EGF-FGF2-free medium supplemented with serum, which favours differentiation (see below). All cultured cells attached to surface of wells and developed differentiated cell morphology. In control cells, this differentiation was non-reversible and complete, as virtually no cells stayed multipotent. This was measured by changing the cells back to EGF-and FGF2-supplemented serum-free medium after 2 weeks of differentiation and counting the possible re-forming neurospheres. Very low number, if any, of re-formed spheres were detected in all E6, E7, p53 þ /À and control virus cells (o10 spheres/200 000 plated cells) (Figure 2a-c) . In contrast, frequent (>2000 spheres/200 000 plated cells) sphere re-formation was seen in E6/E7-expressing cells (Figure 2a-c) . Also p53À/ À cells were able to re-form large numbers of spheres (>400 spheres/200 000 plated cells) after growth factor re-introduction (Figure 2a-c) . The re-formed spheres could be collected, expanded in culture and re-differentiated successfully into both neurons and astrocytes under differentiation-promoting conditions (data not shown).
E6/E7 delays and inhibits terminal mitosis during in vitro differentiation of NPCs To study the cause for sphere re-formation after differentiation, the cells were BrdU pulse labelled for 24 h during different days of differentiation. Bromodeoxyuridine incorporation analysis (Figure 3a and b) showed that virtually all control NPCs withdrew from the cell cycle through terminal mitosis within the first 48-72 h of differentiation. However, NPCs expressing E6/E7 did not undergo terminal mitosis as often, but a major fraction of cells enter S phase (incorporated BrdU) as late as between 168 and 192 h ( Figure 3a ).
Terminal mitosis was also markedly delayed, but complete in p53À/À and E7-expressing cells (Figure 3a and b). We wanted to investigate that the re-formation of spheres and delayed cell cycle exit was not due to major genomic instability occurring in the cells. Therefore, we examined the DNA content of the cells by analysing propidium iodide-stained NPCs in fluorescence-activated cell sorting (FACS) flow cytometer. No disturbance in cell ploidy was seen, as all E6/E7, p53À/À and control NPCs were diploid (Figure 4a -c). The higher proliferation of E6/E7 and p53À/À NPCs was seen as an increase in cell numbers in S and G2M phases.
E6/E7 expression does not block differentiation in NPCs in vitro or in vivo Next we asked whether the E6/E7-induced cell cycle activation and increased self-renewal prevents the NPCs from differentiating. We found no difference in the expression of neural bHLH transcription factors Mash1, Hes1, Hes5 and Id2 (Farah et al., 2000; Toma et al., 2000; Ross et al., 2003) 
In vitro differentiation with fetal calf serum (FCS) produced oligodendrocytes rarely. In both groups, a high proportion (up to 90%) of the cells were still positive for nestin after 96 h in vitro differentiation (data not shown), indicating that cell fate determination was still in process, even though in control group the cells had exited the cell cycle.
To further characterize the differentiation capacity of the cells, we transplanted EGFP-positive E6/E7 and control NPCs into brain ventricles of E14.5 mouse embryos in utero, and after 96 h analysed the colocalization of EGFP and TUJ-1, GFAP or oligodendrocyte marker O4 on serial cryostat sections (Figure 5a-l) . Enhanced green fluorescent protein-positive cells were found all over the brain tissue, most often in the collicular area. Immunohistochemistry showed that E6/ E7-expressing and control NPCs can differentiate in vivo and form all three types of neural cells: neurons, astrocytes and oligodendrocytes (Figure 5a-m) . After in vivo differentiation, the cells in both groups were negative for nestin.
To analyse whether terminal mitosis was delayed or inhibited in the transplanted NPCs, we examined the existence of cells positive for both EGFP and Ki-67 as the marker of proliferating cells. However, no double positive cells were detected either in E6/E7 or controls 96 h after transplantations. Therefore, opposite to our in vitro differentiation assay, the E6/E7-expressing NPCs did not show inhibited terminal mitosis in vivo (data not shown).
Increased pRb expression affects cell proliferation but not self-renewal in E7-and E6/E7-expressing NPCs To examine further pRb involvement in NPC maintenance, E7-and E6/E7-expressing NPCs were transduced with retroviruses carrying pRb under cytomegalovirus promoter (pRb-NIT). After pRb transduction, E7-and E6/E7-expressing NPCs showed a restoration of their pRb level when compared to nontransduced controls (Figure 6a ). No changes in p107 and p130 levels were detected. Restored pRb expression clearly decreased cell proliferation (Figure 6b ), but did not seem to affect the increased self-renewal capacity of E7-or E6/E7-expressing oncogenes (Figure 6c ).
MEK-ERK pathway separates self-renewal from proliferation
To find out the possible signalling pathways mediating the E6/E7 effects, we focused to mitogen-activated protein kinases (MAPKs), the known mediators of cell proliferation, differentiation and cell activation. Extracellular signal-regulated kinase (ERK) pathway is important in self-renewal of some progenitor cells (Dazy et al., 2003) . In epithelial cells, E6 and E7 oncogenes upregulate MAPKs (Antinore et al., 1996; Chakrabarti et al., 2004) . By Western blot, we found a modest but repeatable increase in the level of phosphorylated ERK in undifferentiated E6/E7 NPCs in comparison to controls (Figure 7a ). However, during differentiation induced by FCS, phosphorylated ERK was reduced, and JunD transcription factor in c-Jun NH 2 -terminal protein kinase (JNK) pathway increased in E6/E7 NPCs compared with controls ( Figure 7a ). Also the levels of c-Jun were upregulated in undifferentiated E6/E7-expressing NPCs (Figure 7a ). However, JNK activation did not differ between the groups (Figure 7a) .
To study the difference and connection between cell proliferation and self-renewal, we used MEK-ERK inhibitor U0126 (Favata et al., 1998) and cyclindependent kinase (CDK) inhibitor R-Roscovitine (Meijer et al., 1997). Neural progenitor cells express at least CDK-2, -4, -5 and -6, and all of these except CDK-5 are involved in cell cycle regulation (Ferguson et al., 2000) . R-Roscovitine targets CDK-1, -2, -5, -7 and -9 almost equally (IC 50 values o1 mM) (Bach et al., 2005) . In neurons, MEK-ERK signalling is related to regulation of proliferation, differentiation, neurite outgrowth and synaptic plasticity (reviewed by Grewal et al., 1999) . Our results show that blocking the MEK-ERK pathway decreased proliferation more than 50% of both control and E6/E7 NPCs measured by BrdU (Figure 7b) and MTT (not shown). Interestingly, the effect on selfrenewal was even more dramatic, as the secondary sphere formation was almost completely abolished (Figure 7c ). U0126 did not affect the cell adhesion E6/E7 increase self-renewal K Piltti et al when tested on small spheres, and after removal of U0126 secondary sphere formation returned to the same level as the controls treated with dimethylsulphoxide (DMSO) (data not shown). Inhibiting CDKs also decreased the number of secondary spheres (Figure 7d ) but this decrease in self-renewal was of the same magnitude (50%) than the effect on proliferation probed with BrdU incorporation (Figure 7e ) and MTT assay (data not shown), suggesting that self-renewal and proliferation pathways can be separated.
Discussion
Here we have analysed the effects of common oncogenic alterations on the behaviour of progenitors or stem cells. Our data support the following conclusions: (1) HPV 16 E6, E7 and E6/E7 oncogenes do not block the differentiation potential of the NPCs, but (2) increase cell proliferation and self-renewal, as well as decrease the number of cells undergoing terminal mitosis. (3) Self-renewal and proliferation are linked, but can be separated: pRb restoration decreases only cell proliferation but does not have effect on self-renewal, and MEK/ ERK signalling is more important to self-renewal than proliferation. (4) A fraction of NPCs expressing E6/E7 oncogenes maintain their multipotency in differentiation-promoting environment and are able to re-form neurospheres when the environmental circumstances allow it. However, when placed into highly differentiating environment in vivo, all the cells differentiated without delayed cell cycle exit, suggesting that they are still controlled and able to respond to environmental signals.
We present here the evidence that E6, E7 and E6/E7 oncogenes affect the balance of NPC self-renewal and differentiation. This seems to be linked to the ability of E6/E7 to degrade p53 and pRb family proteins, although viral oncogenes can interfere with several other cellular activities (reviewed by Munger et al., 2004) . We found that E7 oncogene separately increased the number and proportion of cells able to form secondary spheres. Coexpression of E6 and E7 augmented these effects. The high self-renewal capacity of E7-and E6/E7-expressing neurospheres can be thought of as a sign of increased 'stemness' in the heterogeneous mixture of cells in each neurosphere. Therefore, we propose that E6 and E7 expression results in a proportional shift from differentiating NPCs towards a more primitive cell with stem cell characteristics. This increased number of primitive cells is possibly due to an enhanced ratio of symmetric NPC/NSC divisions. 
E6/E7 increase self-renewal K Piltti et al
The mechanisms underlying the adoption of selfrenewal ability of cancer stem cells are not well known. However, most transforming mutations affect tumour suppressor pathways and viral oncogenes like SV40 large T antigen (DeCaprio 1999), BKV TAg (Harris et al., 1998) and adenovirus E1B /E1A oncogenes (Whyte et al., 1988; Dyson et al., 1993) interact with p53 and pRb family members. Our results support the established view that viral oncogenes block tumour suppressor pathways, which control the cell senescence and apoptosis. Additionally, we found that in NPCs they also increase self-renewal, which is an evident advantage and necessary in malignant transformation. Also, by increasing the proportion of stem cells/ progenitors, oncogenes may enlarge the population of primitive and long-lasting cells in tissues, which are potential targets of other transforming mutations. To our knowledge, these functions of viral oncogenes and tumour suppressors have not been described in the nervous system, but they are in accordance with the data about Bmi-1 oncogene, which converges to the same p53 and Rb pathways through p16 E 7 E 7 + R b E 6 / E 7 E 6 / E 7 + R b Figure 6 The increased self-renewal cannot be rescued by restoring pRb in E7-or E6/E7-expressing neural progenitor cells (NPCs (Cheng et al., 1995) . In our work, papilloma virus genes were used as tools and they are normally unlikely to play a role in the central nervous system. p53-deficient mice have an increased number of haematopoietic stem cells (TeKippe et al., 2003) and p53-deficient neuron-like cells are capable of re-entering the cell cycle (Miller et al., 2003) . Our data suggest that p53 is involved in suppressing cell proliferation and selfrenewal in NPCs. We detected re-formation of spheres after growth factor re-introduction in p53-deficient NPCs, even though their cell cycle was initially silenced. However, either E6 or E7 oncogenes alone or p53 þ /À were not sufficient to induce sphere re-formation.
E7 oncogene reduced the levels of all Rb family pocket protein members, pRb, p107 and p130, which have a role in differentiation (Callaghan et al., 1999; Liu et al., 2004) . p107 also regulates the number of selfrenewing NPCs (Vanderluit et al., 2004) . In our hands, restored pRb expression in NPCs expressing E7 or E6/ E7 did not decrease the excess self-renewal but only cell proliferation. Thus, some of the E7-induced effects are most likely mediated through the p107/p130 pathways.
E6/E7 oncogenes did not block the differentiation of NPCs despite low levels of p53 and pRb, both of which have a role in neuronal differentiation (reviewed by Choi and Donehower, 1999) . Remarkably, the E6/E7-expressing NPCs were able to integrate into the developing brain tissue and differentiate into neurons, astrocytes and oligodendrocytes after transplantation Bromodeoxyuridine (BrdU) labelling shows the effect of MEK-ERK inhibitor (50 mM U0126) on cell proliferation (b) in E6/E7-expressing and control NPCs. However, the effect of U0126 on self-renewal capacity in both NPCs is more dramatic (c). Inhibition of cyclin-dependent kinases (10 mM R-Roscovitine) decreases cell proliferation (BrdU) (d) and selfrenewal (e) in NPCs. The decreases in proliferation and self-renewal are of the same magnitude. All charts represent one of three independent experiments. *Po0.05 (Student's t-test). Error bars indicate7s.e.m. replicas.
E6/E7 increase self-renewal K Piltti et al into embryos. Interestingly, all transplanted cells became postmitotic and no proliferating cells were detected. Also nestin expression was downregulated faster than in vitro. It seems that the specific microenvironment in vivo could overrule the proliferative signals and the delay in terminal mitosis observed after in vitro differentiation. Alternatively, it is possible that all proliferating NPCs were destroyed by apoptosis. In culture, MEK-ERK inhibition decreased proliferation about 50% and almost totally blocked the selfrenewal, which suggested that MEK/ERK pathway was essential for maintaining stem cell characteristics. MEK/ ERK pathway is important for self-renewal of immature avian erythroid progenitors (Dazy et al., 2003) , and tumours often have a constitutively active Ras-Raf-MEK-ERK intracellular signalling cascade. E6 and E7 oncogenes upregulate MAPKs in epithelial cells (Antinore et al., 1996; Chakrabarti et al., 2004) , and here we show that in NPCs, E6/E7 oncogenes enhance proliferation and self-renewal through the pathway. In neuronal cells, activation of MEK-ERK signalling has been related to regulation of proliferation, differentiation, neurite outgrowth and synaptic plasticity (reviewed by Grewal et al., 1999) . We also found an increase in another MAPK pathway member, c-Jun, in E6/E7-expressing NPCs when compared to controls. c-Jun is involved in cell proliferation, differentiation, tumour transformation and apoptosis in various cell types (reviewed by Herdegen et al., 1997) . Our results suggest that proliferating E6/E7 NPCs have a higher level of ERK phosphorylation than controls, and the cells do not upregulate this signalling upon differentiation. Here, it is not possible to conclude the exact signalling cascade of increased stemness, but our results suggest that MEK-ERK pathway is involved, especially in proliferative conditions. The experiments with chemical blockers need to be confirmed using other methods, but our data from two different sources suggest that the self-renewal and proliferation can be separated as cell cycle inhibition through CDKs and pRb restoration affected self-renewal much less than blocking of the MEK-ERK pathway.
Materials and methods
Neural progenitor cells
NPCs were collected by dissecting the lateral ventricular wall of embryonic day 11.5 (E11.5) mouse brain (NMRI, UBI-EGFP/BL6, 129/Sv-Trp53 tm1Tyj , Jackson Laboratory, Barharbor, ME, USA). Neurospheres were cultured after clonal division in serum-free medium, which was supplemented with FGF2 and EGF as described in Toma et al. (2001) and gave rise to different neuronal cell types. NIT-EGFP, LXSN-lacZ, empty BABE-vector transduced or untransduced NPCs were used as a control for E6-, E7-and E6/E7-expressing NPCs. All experiments were performed with low passage (o15) cells, even though NPCs could be cultured and maintained for >30 passages without signs of senescence. NPCs were differentiated in FGF2-EGF-free medium supplemented with 2 or 5% FCS (PromoCell, Heidelberg, Germany) on 50 mg/ml poly-L-lysine (Sigma, St Louis, MO, USA) coated glass cover slides, fixed with 4% paraformaldehyde (PFA) and permeabilised with 0.2% Triton X-100 (Sigma) supplemented with 5% FCS.
Retroviruses
For retroviral constructs, we used E6-BABE, E7-BABE and E6/ E7-BABE (Dr D McCance, University of Rochester) or pLXSN-E6/E7 (Halbert et al., 1991) (Dr D Galloway) and for controls empty BABE, pNIT-EGFP (Dr F Gage, La Jolla) or pLXSN-lacZ. For restoring pRb in E7 and E6/E7-expressing NPCs, we cloned human-pRb into pNIT. Viruses were produced in PA317 cell line and transduced into low passage (o5) NPCs with 8 mg/ml polybrene (Sigma). NPCs were selected with 10 mg/ml puromycin dihydrochloride (Sigma) or 400 mg/ml geneticin G418 (Sigma). To exclude the effects of random transgene genomic insertion loci, the in vitro experiments were replicated with NPCs from 3 to 5 different transductions.
RT-PCR
TRIzol reagent (Invitrogen, Carlsbad, CA, USA) was used for total RNA extraction and total RNA (3 mg) was treated with RQ1 DNase (Promega, Madison, WI, USA), denatured at 751C for 5 min and diluted in 10 ml of H 2 O. RNA (5 ml) was incubated for 2 h at þ 371C with random primers and SuperScript II reverse transcriptase (Invitrogen). RNA without RT was diluted into same concentration as cDNA and used as a control for possible genomic DNA contamination. AmpliTaq Gold PCR products (Roche, Nutley, NJ, USA) and 1 ml of each RT reactions and genomic DNA controls were used for 34 cycle PCR amplifications. Primers were designed by using Primer3 program and sequences are as follows:
FACS flow cytometry
To analyze cell cycle and ploidy of NPCs spheres were dispersed into single cells, fixed with 1% PFA and stained with 50 mg/ml propidiumiodide (Sigma) containing 25 mg/ml of RNase. Cells were incubated at 371C for 30 min, sorted with FACSScan flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA) and analyzed with Sync Wizard Model ModFit LT software (Becton Dickinson).
BrdU incorporation, self-renewal capacity test and re-sphere formation after differentiation Cell proliferation was measured with BrdU incorporation kit (Amersham Biosciences, Uppsala, Sweden). To measure the percentage of cells in S-phase, cells were incubated with BrdU (1:1000) for 18 h, cytospinned onto microscope slides and fixed for immunocytochemistry. In terminal mitosis assay, differentiating cells were BrdU labelled for 24 h, and fixed for immunocytochemistry. In figures, the data is modified to correspond to 24 h BrdU incorporation by using formula: (BrdU positive cells (%)/time of incorporation (min)) Â 1440. The self-renewal capacity of NPCs was measured by clonal divisions: 1500 single cells from several neurospheres were plated in a density of 15 cells/well in a 96-well plate and the number of single cell-derived spheres was counted after 7-10 days.
Re-formation of spheres after differentiation was detected after culturing attached single cells in density of 200 000 cells/ well in six-well plates in FGF2-EGF-free medium supplemented with 2% FCS for 14 days. After this period, the medium was replaced with FCS-free medium supplemented with FGF2 and EGF.
Protein extraction, Western blotting and antibodies Protocols for total protein extraction and Western blotting were as described by Popsueva et al. (2003) . For analyzing MAPK pathway activation in control and E6/E7 NPCs, neurospheres were induced with 5% FCS after withdrawal of growth factors for 24 h. Proteins were immunodetected by anti-TUJ-1 (BAbCo, Princeton, NJ, USA or Nordic Biosite, Ta¨by, Sweden), anti-GFAP, anti-O4 (Chemicon, Temencula, CA, USA), anti-GFP (Invitrogen), anti-Ki-67 (NeoMarkers, Fremont, CA, USA), anti-p53 (sc-100 or sc-6243, Santa Cruz, Santa Cruz, CA, USA), anti-Rb (BD Biosciences Pharmingen, San Diego, CA, USA), p107, p130 (Santa Cruz), c-Jun (Cell Signaling, Davers, MA, USA), JunD (Santa Cruz), p-ERK (Promega), ERK (Santa Cruz), p-JNK (Promega), JNK and anti-Actin (Santa Cruz) antibodies. For secondary antibodies, we used Rhodamine Red-X-conjugated goat anti-mouse IgG and FITC-conjugated goat anti-rabbit IgG secondary antibodies (Jackson Immuno Research) or horseradish peroxidase-conjugated secondary antibodies (DAKO, Glostrup, Denmark).
CDK and MAPK pathway inhibitors R-Roscovitine (Alexis Biochemicals, Lausen, Switzerland) was used to inhibit CDKs (1, 2, 5, 7, and 9) and U0126 (Calbiochem, San Diego, CA, USA) for specific inhibition of MEK1 and MEK2 in MAPK pathway. Inhibitors were dissolved to the concentration of 10 mM in DMSO and were used at 10 and 50 mM concentrations, respectively.
Cell transplantations in utero E6/E7-EGFP and EGFP-NIT NPCs were triturated to a single-cell suspension 6 h before transplantation. Pregnant NMRI mice with E14.5 embryos were anesthetized with inhaled Enfluran (Efrane, Abbott Scandinavia, Kista, Sweden) for the entire process. A midline laparotomy was used to expose the uterine horns and the embryos were manipulated in the uterus. B50 000 cells in 1 ml of the cell suspension with 0.05% fast green (Richard-Allan Scientific, Kalamazoo, MI, USA) was injected with a glass capillary attached to a mouth pipette into one of the embryonic brain ventricles. After operation, the mother was sutured and given analgesic. The pregnant mice were killed 4 days after injections; the injected brains were dissected from E18.5 embryos, fixed with 4% PFA, cryoprotected with 30% sucrose overnight and cryosectioned coronally at a thickness of 10-12 mm.
Statistical analysis
All results are shown as mean7s.d. or s.e.m. A two sample unequal variance Student's t-test with two tailed distribution was used to compare the scores after proliferation measured by BrdU or MTT. Po0.05 was considered significant.
